DNAI1

DNAI1 encodes an intermediate chain subunit of the ciliary outer dynein arm (ODA), the macromolecular motor that powers ciliary beating (PMID:16858015). Loss of DNAI1 abolishes ODA assembly: CRISPR-Cas9 disruption in pigs eliminated outer dynein arms from airway cilia and impaired ciliary beating in vivo (PMID:39229081), and DNAI1 mutations in humans occur exclusively in primary ciliary dyskinesia (PCD) patients with a defined ODA ultrastructural defect (PMID:16858015). Compound heterozygous loss-of-function mutations cause PCD with randomized left-right body axis (Kartagener syndrome with situs inversus), linking DNAI1-dependent ciliary motility to laterality determination during development (PMID:11231901). The structural dependence is reversible: restoration of DNAI1 protein by aerosolized or LNP-delivered mRNA in human bronchial epithelial PCD models, nonhuman primate lungs, and conditional knockout mice drives incorporation of newly translated DNAI1 into ciliary axonemes and rescues ciliary beat frequency (PMID:40294271, PMID:40963409).

1. 2001 High

   Established DNAI1 as a disease gene by showing that its loss-of-function couples ciliary motility to left-right axis determination, defining the gene's physiological stakes.

   Evidence Mutation screening and segregation analysis in PCD/Kartagener syndrome patients with confirmed compound heterozygosity

   PMID:11231901

   Open questions at the time

   • Did not resolve which ciliary substructure DNAI1 builds
   • No biochemical demonstration of DNAI1 within the dynein arm
   • Mechanism connecting motility loss to laterality randomization not detailed
2. 2006 High

   Localized DNAI1 function to the outer dynein arm by correlating mutations exclusively with ODA ultrastructural defects across a large PCD cohort.

   Evidence Coding-region sequencing combined with electron-microscopy ODA-defect classification in 179 unrelated PCD families

   PMID:16858015

   Open questions at the time

   • Correlative genotype-ultrastructure link, not a direct knockout test of necessity
   • Did not address DNAI1 role in non-motile cilia
3. 2024 Medium

   Provided direct causal proof that DNAI1 is required for ODA assembly and ciliary motility through targeted gene disruption in vivo.

   Evidence CRISPR-Cas9 knockout pig model with transmission electron microscopy and mucociliary transport assays (preprint)

   PMID:39229081

   Open questions at the time

   • Preprint, single study
   • Mechanism of how DNAI1 nucleates or anchors the ODA not resolved
4. 2024 Low

   Detected DNAI1 in primary (non-motile) cilia and centrioles of pancreatic islets, raising a role beyond classical motile ciliary axonemes.

   Evidence Ultrastructure expansion microscopy with shRNA-knockdown specificity validation in mouse and human islets (preprint)

   Open questions at the time

   • Localization only; no functional consequence established
   • Preprint, single study, no PMID
   • Whether DNAI1 has any role in non-motile cilia signaling unknown
5. 2025 Medium

   Demonstrated that supplying DNAI1 protein is sufficient to rebuild functional ODAs, validating DNAI1 as a structural element whose deficiency is therapeutically reversible.

   Evidence LNP/SORT-LNP DNAI1 mRNA delivery to human bronchial epithelial PCD models, nonhuman primate lungs, and conditional Dnai1 knockout mice with protein detection, axonemal incorporation, and ciliary beat frequency rescue

   PMID:40294271 PMID:40963409

   Open questions at the time

   • Durability and dosing in patient airways not established
   • Stoichiometry and assembly partners of DNAI1 in the ODA not defined
   • Single study per model system

• How DNAI1 assembles with other dynein chains and is targeted into the axoneme, and whether it has any function in non-motile primary cilia, remain open.
• No structural model of DNAI1 within the ODA
• Direct physical partners not biochemically defined in the timeline
• Functional role in primary cilia untested